Advertisement

Mucosal Chronic GVHD Affecting the Oral Pharyngeal, Esophageal, and Anogenital Regions

  • Howard M. ShulmanEmail author
  • David M. Hockenbery
  • Cecilia C. S. Yeung
Chapter

Abstract

Chronic GVHD (cGVHD) targets several regions not affected by acute GVHD (aGVHD), including the oropharynx, the upper portion of the esophagus, and the anogenital region. These regions are surfaced by nonkeratinized squamous mucosa and have similar histology: chronic lymphocytic inflammation with variable apoptosis of the surface. The changes in underlying or adjacent tissues vary by the location resulting in different complications. Oral GVHD results in cheilitis, gum recession, dental decay, and lichen planus-like like streaks on the buccal mucosa, usually accompanied by sicca (see Chap.  17). Esophageal chronic GVHD (cGVHD) frequently presents in patients who have oropharyngeal GVHD and generalized cGVHD. The symptoms are dysphagia and odynophagia. Endoscopy reveals a desquamative sloughing of the mucosa in the upper-to-middle third of the esophagus with formation of synechiae or fibrotic webs. Anogenital involvement of the perianal region, vulva/vagina, and penis leads to lichen sclerosis et atrophicus-like changes with atrophy and stenosis. The symptoms and differential diagnoses of cGVHD in these locations are discussed.

Keywords

Oral GVHD Oral labial biopsy for GVHD Esophageal chronic GVHD Esophageal stenosis and/or web Sloughing esophagitis GERD Anogenital chronic GVHD Vaginal sclerosis Lichen sclerosis et atrophicus and chronic GVHD Lymphocyte adhesion molecules and T-cell targeting 

References

  1. 1.
    Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood. 1994;84(7):2068–101.PubMedGoogle Scholar
  2. 2.
    Petrovic A, Alpdogan O, Willis LM, et al. LPAM (alpha 4 beta 7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease. Blood. 2004;103(4):1542–7.CrossRefGoogle Scholar
  3. 3.
    Zeiser R, Blazar BR. Pathophysiology of chronic graft-versus-host disease and therapeutic targets. N Engl J Med. 2017;377(26):2565–79.CrossRefGoogle Scholar
  4. 4.
    Treister NS, Cook EF Jr, Antin J, Lee SJ, Soiffer R, Woo SB. Clinical evaluation of oral chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2008;14(1):110–5.CrossRefGoogle Scholar
  5. 5.
    Sale GE, Shulman HM, Schubert MM, et al. Oral and ophthalmic pathology of graft versus host disease in man: predictive value of the lip biopsy. Hum Pathol. 1981;12(11):1022–30.CrossRefGoogle Scholar
  6. 6.
    Nakhleh RE, Miller W, Snover DC. Significance of mucosal vs salivary gland changes in lip biopsies in the diagnosis of chronic graft-vs-host disease. Arch Pathol Lab Med. 1989;113(8):932–4.PubMedGoogle Scholar
  7. 7.
    Furquim CP, Pivovar A, Amenabar JM, Bonfim C, Torres-Pereira CC. Oral cancer in Fanconi anemia: review of 121 cases. Crit Rev Oncol Hematol. 2018;125:35–40.CrossRefGoogle Scholar
  8. 8.
    Alter BP. Fanconi anemia and the development of leukemia. Best Pract Res Clin Haematol. 2014;27(3–4):214–21.CrossRefGoogle Scholar
  9. 9.
    Kutler DI, Auerbach AD, Satagopan J, et al. High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. Arch Otolaryngol. 2003;129(1):106–12.CrossRefGoogle Scholar
  10. 10.
    Rosenberg PS, Socie G, Alter BP, Gluckman E. Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood. 2005;105(1):67–73.CrossRefGoogle Scholar
  11. 11.
    Sakai M. Gastrointestinal and hepatic manifestations of chronic graft-versus-host disease. In: Vogelsang G, Pavletic S, editors. Chronic graft-versus-host disease: interdisciplinary management. New York: Cambridge University Press; 2009. p. 216–28.CrossRefGoogle Scholar
  12. 12.
    Parfitt JR, Gregor JC, Suskin NG, Jawa HA, Driman DK. Eosinophilic esophagitis in adults: distinguishing features from gastroesophageal reflux disease: a study of 41 patients. Mod Pathol. 2006;19(1):90–6.CrossRefGoogle Scholar
  13. 13.
    Shulman HM, Kleiner D, Lee SJ, et al. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development project on criteria for clinical trials in chronic graft-versus-host disease: II. Pathology working group report. Biol Blood Marrow Transplant. 2006;12(1):31–47.CrossRefGoogle Scholar
  14. 14.
    McDonald GB, Sullivan KM, Schuffler MD, Shulman HM, Thomas ED. Esophageal abnormalities in chronic graft-versus-host disease in humans. Gastroenterology. 1981;80(5 pt 1):914–21.PubMedGoogle Scholar
  15. 15.
    McDonald GB, Sullivan KM, Plumley TF. Radiographic features of esophageal involvement in chronic graft-vs.-host disease. AJR Am J Roentgenol. 1984;142(3):501–6.CrossRefGoogle Scholar
  16. 16.
    Jagasia MH, Greinix HT, Arora M, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant. 2015;21(3):389–401. e381CrossRefGoogle Scholar
  17. 17.
    Mueller SM, Haeusermann P, Rovo A, et al. Genital chronic GVHD in men after hematopoietic stem cell transplantation: a single-center cross-sectional analysis of 155 patients. Biol Blood Marrow Transplant. 2013;19(11):1574–80.CrossRefGoogle Scholar
  18. 18.
    Zantomio D, Grigg AP, MacGregor L, Panek-Hudson Y, Szer J, Ayton R. Female genital tract graft-versus-host disease: incidence, risk factors and recommendations for management. Bone Marrow Transplant. 2006;38(8):567–72.CrossRefGoogle Scholar
  19. 19.
    Hamilton BK, Goje O, Savani BN, Majhail NS, Stratton P. Clinical management of genital chronic GvHD. Bone Marrow Transplant. 2017;52(6):803–10.CrossRefGoogle Scholar
  20. 20.
    Yared J, Gojo I, Akpek G. Glans penis involvement: an under-recognized manifestation of chronic GVHD. Bone Marrow Transplant. 2012;47(7):1006–7.CrossRefGoogle Scholar
  21. 21.
    Riera C, Deroover Y, Marechal M. Severe vaginal chronic graft-versus-host disease (GVHD): two cases with late onset and literature review. Eur J Gynaecol Oncol. 2010;31(6):703–4.PubMedGoogle Scholar
  22. 22.
    Weinberg JL, Rosenbach M, Kim EJ, Kovarik CL. Lichen sclerosus et atrophicus-like graft-versus-host disease post stem cell transplant. Dermatol Online J. 2009;15(9):4.PubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Howard M. Shulman
    • 1
    • 2
    • 3
    Email author
  • David M. Hockenbery
    • 1
    • 4
    • 5
    • 6
  • Cecilia C. S. Yeung
    • 1
    • 2
    • 3
  1. 1.Clinical Research DivisionFred Hutchinson Cancer Research CenterSeattleUSA
  2. 2.Department of PathologyUniversity of Washington School of MedicineSeattleUSA
  3. 3.Pathology SectionSeattle Cancer Care AllianceSeattleUSA
  4. 4.Human Biology DivisionFred Hutchinson Cancer Research CenterSeattleUSA
  5. 5.Public Health Sciences DivisionFred Hutchinson Cancer Research CenterSeattleUSA
  6. 6.Division of GastroenterologyUniversity of Washington School of MedicineSeattleUSA

Personalised recommendations